Ro-44-3888
Identifiers | |
---|---|
PubChem (CID) | 9907685 |
ChemSpider | 8083337 |
ChEMBL | CHEMBL65267 |
Chemical and physical data | |
Formula | C18H24N4O5 |
Molar mass | 376.4 g/mol |
3D model (Jmol) | Interactive image |
| |
|
Ro 44-3888 is a non-peptidic, selective and reversible glycoprotein IIb/IIIa inhibitor. It is the active metabolite of sibrafiban. It was being investigated as a treatment for heart conditions, including myocardial infarctions. The development of Ro 44-3888 and sibrafiban was discontinued in 1999 following unfavorable Phase III efficacy data.
See also
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.